| The immunology of neuromyelitis optica—current knowledge, clinical implications, controversies and future perspectives M Jasiak-Zatonska, A Kalinowska-Lyszczarz, S Michalak, W Kozubski International journal of molecular sciences 17 (3), 273, 2016 | 125 | 2016 |
| PECAM‐1, a key player in neuroinflammation A Kalinowska, J Losy European journal of neurology 13 (12), 1284-1290, 2006 | 117 | 2006 |
| Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management W Ambrosius, S Michalak, W Kozubski, A Kalinowska International journal of molecular sciences 22 (1), 100, 2020 | 114 | 2020 |
| Acute hepatitis E complicated by acute pancreatitis: a case report and literature review J Jaroszewicz, R Flisiak, A Kalinowska, I Wierzbicka, D Prokopowicz Pancreas 30 (4), 382-384, 2005 | 64 | 2005 |
| Expression of small heat shock proteins in exosomes from patients with gynecologic cancers A Wyciszkiewicz, A Kalinowska-Łyszczarz, B Nowakowski, K Kaźmierczak, ... Scientific reports 9 (1), 9817, 2019 | 56 | 2019 |
| The role of neurotrophins in multiple sclerosis—pathological and clinical implications A Kalinowska-Lyszczarz, J Losy International journal of molecular sciences 13 (10), 13713-13725, 2012 | 52 | 2012 |
| Investigational CC chemokine receptor 2 antagonists for the treatment of autoimmune diseases A Kalinowska, J Losy Expert opinion on investigational drugs 17 (9), 1267-1279, 2008 | 52 | 2008 |
| Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies—the Polish experience A Czarnowska, W Brola, O Zajkowska, S Rusek, M Adamczyk-Sowa, ... Neurologia i Neurochirurgia Polska 55 (2), 212-222, 2021 | 39 | 2021 |
| Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing− remitting multiple sclerosis patients A Kalinowska-Łyszczarz, A Szczuciński, MA Pawlak, J Losy Journal of the neurological sciences 300 (1-2), 81-85, 2011 | 39 | 2011 |
| COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and … M Nojszewska, A Kalinowska, M Adamczyk-Sowa, A Kułakowska, ... Neurologia i Neurochirurgia Polska 55 (1), 8-11, 2021 | 31 | 2021 |
| Immune cell NT-3 expression is associated with brain atrophy in multiple sclerosis patients A Kalinowska-Łyszczarz, MA Pawlak, S Michalak, W Paprzycki, J Losy Journal of neuroimmunology 240, 109-113, 2011 | 25 | 2011 |
| Design of a dual-phase hcp-bcc high entropy alloy strengthened by ω nanoprecipitates in the Sc-Ti-Zr-Hf-Re system L Rogal, Y Ikeda, M Lai, F Körmann, A Kalinowska, B Grabowski Materials & Design 192, 108716, 2020 | 24 | 2020 |
| Cognitive deficit is related to immune-cell beta-NGF in multiple sclerosis patients A Kalinowska-Łyszczarz, MA Pawlak, S Michalak, J Losy Journal of the neurological sciences 321 (1-2), 43-48, 2012 | 24 | 2012 |
| Clinical correlation of multiple sclerosis immunopathologic subtypes WO Tobin, A Kalinowska-Lyszczarz, SD Weigand, Y Guo, N Tosakulwong, ... Neurology 97 (19), e1906-e1913, 2021 | 23 | 2021 |
| sNCAM as a specific marker of peripheral demyelination A Niezgoda, S Michalak, J Losy, A Kalinowska-Łyszczarz, W Kozubski Immunology Letters 185, 93-97, 2017 | 18 | 2017 |
| Symptoms after COVID-19 infection in individuals with multiple sclerosis in Poland A Czarnowska, K Kapica-Topczewska, O Zajkowska, M Adamczyk-Sowa, ... Journal of Clinical Medicine 10 (22), 5225, 2021 | 17 | 2021 |
| Current immunological and clinical perspective on vaccinations in multiple sclerosis patients: are they safe after all? S Witman Tsur, E Adrian Zaher, M Tsur, K Kania, A Kalinowska-Łyszczarz International Journal of Molecular Sciences 22 (8), 3859, 2021 | 17 | 2021 |
| Recommendations for neurological, obstetrical and gynaecological care in women with multiple sclerosis: a statement by a working group convened by the Section of Multiple … A Kalinowska, A Kułakowska, M Adamczyk-Sowa, K Czajkowski, ... Neurologia i Neurochirurgia Polska 54 (2), 125-137, 2020 | 15 | 2020 |
| The levels of circulating proangiogenic factors in migraineurs S Michalak, A Kalinowska-Lyszczarz, D Wegrzyn, A Thielemann, ... Neuromolecular Medicine 19, 510-517, 2017 | 15 | 2017 |
| CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone A Szczuciński, A Kalinowska, J Losy European Neurology 58 (4), 228-232, 2007 | 15 | 2007 |
